<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01761370</url>
  </required_header>
  <id_info>
    <org_study_id>D/05/338</org_study_id>
    <nct_id>NCT01761370</nct_id>
  </id_info>
  <brief_title>Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH)</brief_title>
  <official_title>Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National University Hospital, Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National University Hospital, Singapore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will determine the feasibility of using Bioenteric intragastric balloon (BIB) in&#xD;
      the treatment of patients with Non alcoholic Steatohepatitis (NASH).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Bio-enteric Intra-gastric balloon (BIB) has been shown to be an effective treatment for&#xD;
      weight reduction in obese patients. This study will determine the feasibility of using BIB in&#xD;
      the treatment of patients with Non alcoholic Steatohepatitis (NASH). It will evaluate the&#xD;
      efficacy of the BIB in improving histology of NASH in obese patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2005</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in liver histology</measure>
    <time_frame>6 months</time_frame>
    <description>The primary outcome measure was liver histology before and after treatment. Assessment of disease activity was done with the use of the NAS, which grades steatosis, lobular inflammation and hepatocellular ballooning.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Non Alcoholic Steatohepatitis</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AHA diet plus exercise with BIB placement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>AHA diet plus exercise with sham BIB placement</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>AHA diet plus exercise with BIB placement</intervention_name>
    <description>AHA diet plus exercise with BIB placement for 6 months</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>AHA diet plus exercise with sham BIB placement</intervention_name>
    <description>AHA diet plus exercise with sham BIB placement</description>
    <arm_group_label>Sham control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients between 21-65 years of age,&#xD;
&#xD;
          -  Had histological evidence of NASH,&#xD;
&#xD;
          -  Had a BMI of greater than 27kg/m2, and&#xD;
&#xD;
          -  Had failed at least 6 month trial of medical therapy for weight reduction.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with any organic disease of the upper GI tract,&#xD;
&#xD;
          -  Were receiving anti-inflammatory drugs,&#xD;
&#xD;
          -  Anticoagulants or steroids, or&#xD;
&#xD;
          -  Had a history of alcoholism or drug addiction. A hiatus hernia of &gt; 5 cm, an active&#xD;
             gastric or duodenal ulcer, and prior or intestinal surgery were considered&#xD;
             contraindications to the placement of BIB.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yin Mei Lee, MBChB</last_name>
    <role>Principal Investigator</role>
    <affiliation>National University Hospital, Singapore</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>119074</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <study_first_submitted>November 1, 2011</study_first_submitted>
  <study_first_submitted_qc>January 3, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 4, 2013</study_first_posted>
  <last_update_submitted>January 3, 2013</last_update_submitted>
  <last_update_submitted_qc>January 3, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Non alcoholic Steatohepatitis</keyword>
  <keyword>Intra-gastric balloon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

